Hi , there have been ocasi okns were the status are not updated. Mesoblast has conducted ards trial and last i checked few weeks back its status wasnt changed.
But since you raised the point it made we curious why the status isn't updated if my above reason is not the case.
i dug in to all the fda requests submitted by nanose and i found a trial where the end date is April 2021 which is what we have been told would be a month of announcement.
Hide glossary
Glossary
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Search for terms
x
Accepts healthy volunteers
Active comparator arm
Adverse event
Age or age group
All-cause mortality
Allocation
Arm
Arm type
Baseline characteristics
Canceled submission
Certain agreements
Certification
Certification/extension first posted
Certification/extension first submitted
Certification/extension first submitted that met QC criteria
City and distance
Clinical study
Clinical trial
ClinicalTrials.gov identifier (NCT number)
Collaborator
Condition/disease
Contact
Country
Cross-over assignment
Data Monitoring Committee (DMC)
Early Phase 1 (formerly listed as Phase 0)
Eligibility criteria
Enrollment
Exclusion criteria
Expanded access
Expanded access status
Expanded access type
Experimental arm
Extension request
Factorial assignment
FDAAA 801 Violations
First posted
First submitted
First submitted that met QC criteria
Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801)
Funder type
Gender-based eligibility
Group/cohort
Human subjects protection review board
Inclusion criteria
Informed consent
Informed consent form (ICF)
Intervention model
Intervention/treatment
Interventional study (clinical trial)
Investigator
Last update posted
Last update submitted
Last update submitted that met QC criteria
Last verified
Listed location countries
Location terms
Masking
NCT number
No intervention arm
Observational study
Observational study model
Other adverse event
Other study IDs
Other terms
Outcome measure
Parallel assignment
Participant flow
Patient registry
Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase Not Applicable
Placebo
Placebo comparator arm
Primary completion date
Primary outcome measure
Primary purpose
Principal investigator (PI)
Protocol
Quality control (QC) review
Randomized allocation
Recruitment status
Registration
Removed location countries
Reporting group
Responsible party
Results database
Results delayed
Results first posted
Results first submitted
Results first submitted that met QC criteria
Results returned after quality control review
Results submitted to ClinicalTrials.gov
Secondary outcome measure
Serious adverse event
Sex
Sham comparator arm
Single group assignment
Sort studies by
Sponsor
State
Statistical analysis plan (SAP)
Status
Study completion date
Study design
Study documents
Study IDs
Study record
Study registry
Study results
Study start date
Study type
Submitted date
Title
Title acronym
U.S. Agency for Healthcare Research and Quality (AHRQ)
U.S. Food and Drug Administration (FDA)
Unknown
Skip to Main Content


Home
Search Results
Study Record Detail
Save this study
Trial record 7 of 15 for: Na-nose
Previous Study | Return to List | Next Study
Detection of Placenta Accreta Via Exhaled Women Breath
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03947047
Recruitment Status : Recruiting
First Posted : May 13, 2019
Last Update Posted : August 13, 2019
See Contacts and Locations
Sponsor:
HaEmek Medical Center, Israel
Collaborator:
Technion, Israel Institute of Technology
Information provided by (Responsible Party):
Sivan Easton, HaEmek Medical Center, Israel
Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record
all trials details
https://clinicaltrials.gov/ct2/show/NCT03947047?term=Na-nose&draw=2&rank=7
- Forums
- ASX - By Stock
- BRN
- FDA submission of Nanose medical
FDA submission of Nanose medical, page-6
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $380.4M |
Open | High | Low | Value | Volume |
21.0¢ | 22.0¢ | 20.3¢ | $1.148M | 5.421M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 165683 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 100708 | 0.205 |
31 | 1352880 | 0.200 |
20 | 1078950 | 0.195 |
73 | 2649418 | 0.190 |
39 | 1624922 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 197658 | 4 |
0.220 | 890202 | 24 |
0.225 | 627180 | 16 |
0.230 | 562701 | 21 |
0.235 | 243642 | 14 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |